Regional
EMS Region VII Bioterrorism and All Hazards Preparedness Committee
Drugs and doses23
A–C Adenosine, Albuterol, Amiodarone, Atropine, Calcium Gluconate5
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 18, 75, 76 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 18, 75, 76 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 5 mg | NEB | not captured | standing | page 35 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 10 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 47 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 48 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 10 |
| Other | adult | 5 mg | NEB | not captured | standing | page 35 |
| Other | adult | 5 mg | NEB | not captured | standing | page 36 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 79 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 77 |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | page 77 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 17, 73 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 17, 73 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 21, 74 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 21, 74 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 74 |
| Other | adult | 2 mg | IV/IO | not captured | standing | page 59 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 59 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 g | IV/IO | not captured | standing | page 35 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 20 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 36 |
| Other | adult | 1 g | IV | not captured | standing | page 20 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 35 |
D–F Dextrose, Diphenhydramine, Epinephrine, Fentanyl, Furosemide5
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mL | IV/IO | not captured | standing | pages 49, 50, 51, 52, 73, 80, 83, 84 |
| Other | adult | 50 mL | IV | not captured | standing | page 52 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | pages 49, 50, 51, 52, 73, 80, 83, 84 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | page 84 |
| Other | peds | 4 mL/kg | IV/IO | not captured | standing | page 73 |
| Other | peds | 4 mL/kg | IV/IO | not captured | standing | page 84 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | IV | not captured | standing | pages 48, 82 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | pages 48, 82 |
| Anaphylaxis | peds | 1 mg/kg | IV | not captured | standing | pages 48, 82 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | pages 48, 82 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1 mg | IV/IO | not captured | standing | pages 48, 82 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 48, 82 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 48, 82 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 48, 82 |
| Bradycardia | adult | 0.5 mL | IV/IO | not captured | standing | pages 21, 74 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 21, 74 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 15, 17, 20, 73 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 15, 17, 20, 73 |
| Cardiogenic shock | adult | 0.5 mL | IV/IO | not captured | standing | pages 16, 21 |
| Other | adult | 0.1 mg | IV/IO | not captured | standing | page 48 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 47 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 47 |
| Other | adult | 0.5 mL | IV/IO | not captured | standing | page 16 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 73 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 82 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | page 37 |
| Burns | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 37 |
| Crush injury | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | page 35 |
| Crush injury | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 35 |
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | page 99 |
| Other | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | page 34 |
| Other | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | pages 54, 87 |
| Other | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 34 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | page 99 |
| Other | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 54, 87 |
| Severe pain | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | pages 11, 72 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 11, 72 |
| Post-intubation sedation | adult | 1 mcg/kg | IV/IO | not captured | standing | page 100 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 100 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–40 mg | IV | not captured | standing | page 23 |
G–L Glucagon, Ipratropium, Ketamine3
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IM/IN | not captured | standing | pages 49, 50, 51, 52, 83, 84, 85 |
| Other | adult | 1 mg | IN | not captured | standing | page 49 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | NEB | not captured | standing | page 10 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 47 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 48 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 10 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 79 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 77 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 77 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg/kg | IM | not captured | standing | page 94 |
| RSI induction | adult | 2 mg/kg | IV/IO/IM/IN | not captured | standing | page 99 |
| RSI induction | peds | 2 mg/kg | IV/IO/IM/IN | not captured | standing | page 99 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 47 |
| Seizure | adult | 4 g | IV | not captured | standing | pages 52, 65 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | pages 48, 82 |
| Anaphylaxis | peds | 2 mg/kg | IV | not captured | standing | pages 48, 82 |
| Other | adult | 125 mg | IV | not captured | standing | page 47 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 18, 75 |
| Other | adult | 5 mg | IV/IO/IM/IN | not captured | standing | page 99 |
| Other | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 18, 75 |
| Other | peds | 0.15 mg/kg | IM/IN | not captured | standing | page 99 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 99 |
| Post-intubation sedation | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | page 100 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 100 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 21, 103 |
| RSI induction | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | page 99 |
| RSI induction | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 99 |
| Seizure | adult | 5 mg | IV/IO/IM/IN | not captured | standing | pages 52, 70, 83 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 52, 70, 83 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 5 mg | IV/IO/IM | not captured | standing | page 37 |
| Burns | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 37 |
| Crush injury | adult | 5 mg | IV/IO/IM | not captured | standing | page 35 |
| Crush injury | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 35 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | page 34 |
| Other | adult | 5 mg | IV/IO/IM | not captured | standing | pages 54, 87 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 34 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 54, 87 |
| Severe pain | adult | 2 mg | IV/IO/IM | not captured | standing | pages 11, 72 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 11, 72 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IN | not captured | standing | pages 20, 50, 51, 80, 85 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 50, 51, 80, 85 |
| Other | peds | 2 mg | IN | not captured | standing | page 85 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | page 22 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 23 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/ODT | not captured | standing | page 7 |
| Nausea / vomiting | peds | 4 mg | IV/ODT | not captured | standing | page 7 |
| Other | adult | 4 mg | ODT | not captured | standing | page 7 |
| Other | peds | 4 mg | ODT | not captured | standing | page 7 |
S–Z Sodium Bicarbonate, Tetracaine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 35 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | page 20 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | page 36 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | OPH | not captured | standing | page 58 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 29 |
Cite this
EMS Region VII Bioterrorism and All Hazards Preparedness Committee, United States EMS Protocol Census. 117 dose entries, effective 2024-12-01.
https://protoquiz.com/census/agencies/ems-region-vii-bioterrorism-and-all-hazards-preparedness-committee/
The census is free and not for sale. Only public agencies are named.